Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults
Clinical trial NCT06500299 · UNKNOWN
Trial details
- NCT number
- NCT06500299
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-15
- Primary completion
- 2024-10-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.